China Shineway Pharmaceutical Group Ltd
HKEX:2877
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
China Shineway Pharmaceutical Group Ltd
HKEX:2877
|
CN |
|
Jiangsu Xiehe Electronic Co Ltd
SSE:605258
|
CN |
|
A
|
Amneal Pharmaceuticals Inc
F:2DT
|
US |
|
Panoramic Resources Ltd
ASX:PAN
|
AU |
|
A
|
Aveanna Healthcare Holdings Inc
NASDAQ:AVAH
|
US |
|
D
|
Doosan Robotics Inc
KRX:454910
|
KR |
|
A
|
Aegean Airlines SA
ATHEX:AEGN
|
GR |
Wall Street
Price Targets
Price Targets Summary
China Shineway Pharmaceutical Group Ltd
According to Wall Street analysts, the average 1-year price target for China Shineway Pharmaceutical Group Ltd is 8.67 HKD with a low forecast of 8.59 HKD and a high forecast of 8.93 HKD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is China Shineway Pharmaceutical Group Ltd's stock price target?
Price Target
8.67
HKD
According to Wall Street analysts, the average 1-year price target for China Shineway Pharmaceutical Group Ltd is 8.67 HKD with a low forecast of 8.59 HKD and a high forecast of 8.93 HKD.
What is China Shineway Pharmaceutical Group Ltd's Revenue forecast?
Projected CAGR
-4%
For the last 13 years the compound annual growth rate for China Shineway Pharmaceutical Group Ltd's revenue is 5%. The projected CAGR for the next 3 years is -4%.
What is China Shineway Pharmaceutical Group Ltd's Operating Income forecast?
Projected CAGR
1%
For the last 13 years the compound annual growth rate for China Shineway Pharmaceutical Group Ltd's operating income is 1%. The projected CAGR for the next 3 years is 1%.
What is China Shineway Pharmaceutical Group Ltd's Net Income forecast?
Projected CAGR
8%
For the last 13 years the compound annual growth rate for China Shineway Pharmaceutical Group Ltd's net income is 1%. The projected CAGR for the next 3 years is 8%.
